HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Clinical trials for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN trials appear
Sign up with your email to follow new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could prevent Life-Threatening fetal anemia in High-Risk pregnancies
Disease control Recruiting nowThis phase 3 trial tests whether the drug nipocalimab can reduce the risk of severe anemia in unborn babies whose mothers have a condition called hemolytic disease of the fetus and newborn (HDFN). The study enrolls 120 pregnant women with a history of severe HDFN. Participants re…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New registry aims to understand anemia in newborns with blood disease
Knowledge-focused Recruiting nowThis study is a global registry that will follow 175 pregnant people whose babies are at risk for hemolytic disease of the fetus and newborn (HDFN), a condition where the mother's and baby's blood types clash, causing rapid red blood cell breakdown. Researchers will track how oft…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC